Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a lymphoproliferative syndrome characterized by small monomorphic CD19+ B-cells that frequently co-express CD5, CD23, and CD200, with weak CD20 and surface immunoglobulin expression [1]. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.